Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2013-09-30
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Assessments are made before first chemotherapy cycle and after fourth chemotherapy cycle, an expected average of 12 weeks between first and second assessment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection
NCT00450125
Feasibility of Exercise With Post-Op Lung Cancer Patients
NCT00636571
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
NCT05823740
Exercise Study in Patients With Lung Cancer
NCT01581346
Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer
NCT03066271
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lung cancer patients
Non Small Cell Lung Cancer, Small Cell Lung Cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Small cell lung cancer
* Patients \>18 years
* WHO performance status 0-2
* undergoing chemotherapy
Exclusion Criteria
* myocardial infarction diagnosed within the last month
* not approval for physical activity by primary oncologist
* inability to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Quist
phd student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seppo Langer, Phd.
Role: STUDY_CHAIR
University Hospital of Copenhagen, Rigshospitalet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-58-0015-30-1059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.